Assessing the Risk of Malignancy in Patients with Multiple Sclerosis Receiving Subcutaneous Interferon beta-1a

被引：0
|
作者：
Sandberg-Wollheim, Magnhild
Kornmann, Gabrielle
Moraga, Margaretha Stam
Miret, Montserrat
Alteri, Enrica
机构：
来源：
NEUROLOGY | 2010年 / 74卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A61 / A62
页数：2
相关论文
共 50 条
  • [1] Risk of stroke in patients with multiple sclerosis treated with subcutaneous interferon beta-1a
    Sabido-Espin, M.
    Venkatesh, S.
    Aldridge, J.
    Gillett, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 1022 - 1022
  • [2] Evaluation of the risk of malignancies in patients with multiple sclerosis treated with subcutaneous interferon beta-1a
    Alteri, E.
    Kornmann, G.
    Moraga, M. Stam
    Casset-Semanaz, F.
    Miret, M.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S204 - S205
  • [3] Risk of Stroke in Patients with Multiple Sclerosis Treated with Subcutaneous Interferon beta-1a (scIFNβ-1a)
    Sabido, Meritxell
    Venkatesh, Saritha
    Aldridge, Julie
    Gillett, Alan
    [J]. NEUROLOGY, 2018, 90
  • [4] Subcutaneous Interferon beta-1a Treatment and Pregnancy Outcomes in Patients with Multiple Sclerosis
    Sandberg-Wollheim, Magnhild
    Alteri, Enrica
    Moraga, Margaretha Stam
    Kornmann, Gabrielle
    [J]. NEUROLOGY, 2010, 74 (09) : A404 - A404
  • [5] Subcutaneous Interferon Beta-1a in Pediatric Multiple Sclerosis: A Retrospective Study
    Tenembaum, Silvia N.
    Banwell, Brenda
    Pohl, Daniela
    Krupp, Lauren B.
    Boyko, Alexey
    Meinel, Michael
    Lehr, Lorenz
    Rocak, Sanda
    di Cantogno, Elisabetta Verdun
    Moraga, Margaretha Stam
    Ghezzi, Angelo
    [J]. JOURNAL OF CHILD NEUROLOGY, 2013, 28 (07) : 849 - 856
  • [6] Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a
    Pohl, D
    Rostasy, K
    Gärtner, J
    Hanefeld, F
    [J]. NEUROLOGY, 2005, 64 (05) : 888 - 890
  • [7] COMPARISON OF MEDICATION ADHERENCE TO INTERFERON BETA-1B AND INTERFERON BETA-1A SUBCUTANEOUS IN MULTIPLE SCLEROSIS PATIENTS
    Meletiche, D. M.
    Kozma, C.
    Dickson, M.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A194 - A194
  • [8] IMPACT OF ADHERENCE ON SUBCUTANEOUS INTERFERON BETA-1A EFFECTIVENESS ADMINISTERED BY REBISMART® IN PATIENTS WITH MULTIPLE SCLEROSIS
    Edo-Solsona, M.
    Monte-Boquet, E.
    Casanova-Estruch, B.
    Poveda-Andres, J.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A435 - A435
  • [9] Development of an electronic device for subcutaneous injection of interferon beta-1a in patients with relapsing multiple sclerosis
    Mikol, D.
    Verdun, E.
    Exell, S.
    Devonshire, V.
    [J]. MULTIPLE SCLEROSIS, 2010, 16 (10): : 1282 - 1282
  • [10] Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart® in patients with multiple sclerosis
    Edo Solsona, Maria Dolores
    Monte Boquet, Emilio
    Casanova Estruch, Bonaventura
    Poveda Andres, Jose Luis
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 415 - 421
12345